| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.002 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |